---
title: "COSCIENS BIOPHARMA INC (CSCIF.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/CSCIF.US/norm.md"
symbol: "CSCIF.US"
name: "COSCIENS BIOPHARMA INC"
parent: "https://longbridge.com/zh-CN/quote/CSCIF.US.md"
datetime: "2026-03-16T04:29:13.510Z"
locales:
  - [en](https://longbridge.com/en/quote/CSCIF.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CSCIF.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CSCIF.US/norm.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/CSCIF.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/CSCIF.US/norm.md)


# COSCIENS BIOPHARMA INC (CSCIF.US) — 财务报表

## 利润表 (USD)

| 指标 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.5725 | -0.8507 | -1.16 | -2.14 | -1.85 |
| ROE | -119.50% | -125.33% | -125.47% | -162.31% | -99.57% |
| Revenue | 1.48M | 2.75M | 1.50M | 3.32M | 1.87M |
| Net income | -1.82M | -2.70M | -3.65M | -6.73M | -5.75M |
| Operating income | -2.08M | -2.35M | -3.62M | -3.61M | -4.83M |
| Gross margin | 36.75% | 35.43% | 29.53% | 61.68% | 51.15% |
| Net margin | -122.66% | -98.25% | -243.67% | -202.62% | -307.59% |
| Profit quality | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 23.86M | 27.56M | 31.14M | 35.07M | 43.77M |
| Leverage | 4.70 | 3.88 | 3.07 | 2.66 | 2.19 |
| BVPS | 1.60 | 2.24 | 3.22 | 4.19 | 6.41 |
| Turnover | 0.2678 | 0.2433 | 0.2870 | 0.3260 | 0.2186 |
| Cash & STI | 8.52M | 9.33M | 13.76M | 16.39M | 20.00M |
| Inv & Rec | 1.76M | 1.82M | 2.46M | 2.69M | 3.31M |
| LT assets | 9.89M | 10.92M | 10.66M | 10.97M | 11.81M |
| Net debt | -6.35M | -7.08M | -11.53M | -14.08M | -18.38M |

## 现金流量表 (USD)

| 指标 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -676000.00 | -4.45M | -1.88M | -3.00M | -7.78M |
| Investing CF | 4000.00 | -48000.00 | -615000.00 | -316000.00 | 83000.00 |
| Financing CF | -85000.00 | -107000.00 | -200000.00 | -202000.00 | -188000.00 |
| Free CF | -774875.00 | -3.33M | -1.70M | -2.68M | -6.79M |
| OCF coverage | -795.29% | -3900.88% | -230.67% | -717.46% | -3175.10% |
| Repaid & issued | - | - | - | - | - |
| CapEx | - | -49000.00 | -615000.00 | -309000.00 | -131000.00 |